CELLERON THERAPEUTICS
An innovative oncology healthcare company The future of cancer therapy lies in the ability to match patients to treatments they will respond favourably to. Celleron has developed biomarkers using epigenetic techniques that match drugs to responsive disease. Their portfolio of technologies can be used to develop a new class of mechanism-based cancer drugs. Drugs that will improve the success rates of treatment, reduce the side effects in patients and deliver more cost effective healthcare.
CELLERON THERAPEUTICS
Industry:
Biotechnology Health Care
Founded:
2005-01-01
Address:
Abingdon, Oxfordshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.cellerontherapeutics.com
Total Employee:
1+
Status:
Active
Contact:
4407766255216
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
Acthera Therapeutics
Acthera Therapeutics is developing an innovative nanotechnology-based platform for the controlled and targeted drug delivery
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
InProTher
InProTher is an immuno therapy company dedicated to developing the world’s first adaptive immune therapy.
Current Employees Featured
Founder
Investors List
KTB Network
KTB Network investment in Venture Round - Celleron Therapeutics
Korea Investment Partners
Korea Investment Partners investment in Venture Round - Celleron Therapeutics
NHN Investment
NHN Investment investment in Venture Round - Celleron Therapeutics
IMM Investment
IMM Investment investment in Venture Round - Celleron Therapeutics
Official Site Inspections
http://www.cellerontherapeutics.com
- Host name: 95.179.239.122.vultrusercontent.com
- IP address: 95.179.239.122
- Location: London United Kingdom
- Latitude: 51.5128
- Longitude: -0.0638
- Timezone: Europe/London
- Postal: E1
More informations about "Celleron Therapeutics"
Celleron Therapeutics - Crunchbase Company Profile
Contact Email [email protected] Phone Number 4407766255216 Celleron Therapeutics An innovative oncology healthcare …See details»
Celleron Therapeutics - Org Chart, Teams, Culture
View Celleron Therapeutics' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Celleron Therapeutics - 2025 Company Profile - Tracxn
Mar 12, 2025 Celleron Therapeutics is focussed on developing drugs targeting epigenetic control for the treatment of cancer. Its drug pipeline includes CXD101, a novel HDAC (histone …See details»
Celleron Therapeutics Ltd. - Drug pipelines, Patents, Clinical trials ...
Www.cellerontherapeutics.com. Last update 23 Jan 2025. Overview. Pipeline. Deal. Translational Medicine. Profit. Grant & Funding(NIH) Investment. Financing. Overview. ... The statistics for …See details»
Celleron Therapeutics Company Profile: Overview and Full News …
Cellerontherapeutics.com. Oncology. Overview: Celleron Therapeutics. Celleron Therapeutics, located in Oxfordshire, is a clinical-stage biopharmaceutical company focused on developing …See details»
Celleron Therapeutics - PitchBook
Information on acquisition, funding, cap tables, investors, and executives for Celleron Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
Celleron Therapeutics - Overview, News & Similar companies
Aug 12, 2020 Popular Searches Celleron Therapeutics Ltd Celleron Therapeutics Cellerontherapeutics SIC Code 87,873 NAICS Code 54,541 Show more. Similar Companies to …See details»
Celleron Therapeutics and Argonaut Therapeutics Announce
Jan 5, 2023 For more information see www.cellerontherapeutics.comAbout Argonaut Therapeutics. Argonaut Therapeutics is a preclinical-stage biotech company focusing on the …See details»
Celleron Therapeutics (UK) Funding: $16M - medicalstartups.org
Feb 10, 2025 Celleron is building a global oncology company focussed on the clinical development of new and innovative therapies to treat...See details»
Celleron Therapeutics Ltd.:Company Profile & Technical Research ...
Celleron Therapeutics is a company that provides Health care, Clinical trial, Enzyme and more. Celleron Therapeutics is headquartered in United Kingdom Oxfordshire.See details»
Celleron Therapeutics Overview | SignalHire Company Profile
Celleron Therapeutics is a private company that has been in the industry for 17 years. The company currently specializes in the Biotechnology, Pharmaceuticals, Biotechnology areas. …See details»
Celleron Therapeutics enters into a license agreement with Roche …
Aug 12, 2020 www.cellerontherapeutics.com About emactuzumab Emactuzumab (RG7155) is an investigational monoclonal IgG1 antibody designed to target and deplete tumour …See details»
CELLERON THERAPEUTICS LIMITED - Companies House
CELLERON THERAPEUTICS LIMITED - Free company information from Companies House including registered office address, filing history, accounts, annual return, officers, charges, …See details»
Celleron Therapeutics appoints global financier Richard Taylor as …
Https://cellerontherapeutics.com ® ® 1/1 Celleron Therapeuics appoints global financier Richard Taylor as new Board Director Oxford, UK, 27th Sep 2021 – Celleron Therapeuics, the UK …See details»
Celleron Therapeutics Ltd. (Celleron Therapeutics Ltd.) - 药物管线_ …
了解Celleron Therapeutics Ltd. (Celleron Therapeutics Ltd.)公司的药物管线，治疗领域，技术平台，以及它的2项临床试验, 5篇新闻和3篇文献，药物:Zabinostat，CT-200，CT …See details»
Celleron Therapeutics and Argonaut Therapeutics Announce …
For more information see www.cellerontherapeutics.com About Argonaut Therapeutics Argonaut Therapeutics is a preclinical-stage biotech company focusing on the research and discovery of …See details»
Celleron Therapeutics Spins Out SynOx Therapeutics which
Oxford, November 30, 2020 – Celleron Therapeutics, the UK-based company developing personalised medicines for cancer patients, announces the formation of a new spin out, …See details»
Inside the futuristic biotech startup Cellares that’s building a cure ...
1 day ago Inside the futuristic biotech startup Cellares that’s building a cure for cancer with $355 million in fundingSee details»
Celleron Therapeuics’ CXD101 shows promising clinical results in …
Https://cellerontherapeutics.com ® ® 1/2 Celleron Therapeuics’ CXD101 shows promising clinical results in its China IND programme with partner Nuance Biotech Oxford, UK, 6th July 2021 – …See details»
Celleron Therapeutics reports 3-year survival data from Phase II ...
Jun 29, 2022 https://cellerontherapeutics.com ® ® 2/3 NOTES: About Colorectal Cancer Colorectal cancer is the second most common tumour type in women, and the third most …See details»